Results 121 to 130 of about 2,544,276 (249)
Abstract Drug‐resistant epilepsy (DRE) affects approximately one‐third of patients with epilepsy and represents a major unmet clinical need. While traditional hypotheses of pharmacoresistance have focused on alterations in drug targets, efflux transporter overexpression, and intrinsic disease severity, the gut microbiome has recently emerged as a ...
Khaled Zammar +4 more
wiley +1 more source
Thrombophilic Risk Factors in Epileptic Children Treated with Valproic Acid
There are few reports on valproic acid related to thrombophilia. Thrombophilic risk factors were investigated in 21 children (age range, 1-13 years) diagnosed with epilepsy and newly treated with valproic acid monotherapy.
Deda, Guelhis +4 more
core +1 more source
Abstract Objective Cannabidiol (CBD) has demonstrated promising effectiveness and tolerability as adjunctive treatment in patients with severe childhood epilepsies. This study investigated the effectiveness and tolerability of CBD in adults with a history of Dravet syndrome (DS), Lennox–Gastaut syndrome (LGS), or tuberous sclerosis complex (TSC ...
Sara Sánchez‐Gamino +7 more
wiley +1 more source
Hyperammonemia and valproic acid-induced encephalopathy
Full Text: To The Editor: We read with great interest the thought-provoking clinical case conference by Russell B. Carr, M.D., and Kerrie Shrewsbury, M.D., in the July 2007 issue of the Journal describing the difficulty in predicting hyperammonemia ...
Modjtahedi , Bobeck
core
Economic burden and cost determinants of epilepsy in Georgia: A longitudinal cost‐of‐illness study
Abstract Objective To assess the economic burden, cost components, and individual‐level determinants of outpatient epilepsy care in adults in Georgia. Methods This longitudinal study of epilepsy‐related costs in adults with active epilepsy attending a tertiary epilepsy centre in Tbilisi collected clinical and sociodemographic data over 6 months. Direct
Sofia Kasradze +5 more
wiley +1 more source
This graphical abstract provides an overview of the content from this post hoc analysis evaluating the efficacy and safety of fenfluramine in patients with Dravet syndrome stratified by age, number of previously attempted antiseizure medications, and SCN1A pathogenic variant status using data pooled from the three pivotal randomized controlled trials ...
Rima Nabbout +20 more
wiley +1 more source
Hypoalbuminemia with valproic acid administration.
Valproic acid and its derivatives are commonly administered antiepileptic drugs for children and adults. Five residents at a children\u27s long-term care facility manifested hypoalbuminemia while being administered divalproex, although serum liver ...
Bilat, Carol A +3 more
core +1 more source
Hongqiang Wu,1–3,* Jian Ding,1–3,* Lei Wang,3 Jinti Lin,1–3 Shihen Li,1–3 Guangheng Xiang,1–3 Liangfu Jiang,1–3 Huazi Xu,1–3 Weiyang Gao,1–3 Kailiang Zhou1–3 1Department of Orthopaedics, The Second ...
Jiang L +9 more
core
Abstract Objective To evaluate the effectiveness and tolerability of cenobamate in patients with a significant reduction in concomitant antiseizure medication (ASM) in European cenobamate Early Access Programs (EAPs). Method Anonymized patient data from real‐world studies/registries associated with European cenobamate EAPs were pooled.
Vicente Villanueva +25 more
wiley +1 more source
Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy
This study was performed in order to determine the effects of valproic acid on serum free carnitine, beta-hydroxybutyrate and blood amamonia.
H B Toksoy, F N Tanzer, A Atalay
doaj

